Haematuria (urology) Flashcards
Define AKI
Sudden deterioration in kidney function
NICE specifications for presence of AKI
- urine output <0/5ml/kg for 6 hours
- > 50% rise in creatinine over 7 days
- 26 micromol rise in creatinine over 48 hours
Serum creatinine and urine output in AKI stage 1
Serum creatinine: 150-200% increase or 25 umol/l increase in 48h
Urine output: <0.5ml/kg/h for 6h
Serum creatinine and urine output in AKI stage 2
Serum creatinine: 200-300% increase
Urine output: 0.5 ml/kg/h for 12 h
Serum creatinine and urine output in AKI stage 3
Serum creatinine: >300% increase or >350umol/l with acute rise of >45umol/l in 48h
Urine output: <0.3ml/kg/h for 24h or anuria for 12h
What is pre-renal AKI
Occurs when the blood supply to the kidney is interrupted
2 causes:
- shock : hypovolemic, cardiogenic, distributive
- renovascular obstruction: aortic dissection, renal artery stenosis, ACEi
What is acute tubular necrosis
Prolonged interruption to the blood supply ischaemia leads to necrosis of the cells that line the renal tubules
- leads to porous tubular membranes and also blockage of the tubules by necroses cells
- urine is isotonic with plasma and has high sodium as concentrating powers are lost
What is post renal AKI
Occurs when there is obstruction to the outflow of the urinary tract
Leads to back flow of urine, damage to the kidney architecture and resultant organ failure
Blockage is often in the ureters
3 causes / mechanisms of renal AKI
Acute tubular necrosis (85%)
Interstitial nephritis (10%)
Glomerular disease (5%)
Causes of acute tubular necrosis
Drugs: aminoglycosides, cephalosporins, radiological contrast mediums, NSAIDs
Toxins: heavy metal poisoning, myoglobinuria, haemolytic uraemic syndrome
Pathophysiology of interstitial nephritis
Mainly caused by drugs
Damage is not limited to tubular cells and bypasses the BM to cause damage to the interstitium
- mainly caused by abx, diuretics, PPI, allopurinol
Management of interstitial nephritis
Withdrawal of the drugs and a short course of oral steroids
Anatomy of the glomerulus
3 layers for substances to pass through
1. Fenestrated capillary epithelium
2. BM
3. Visceral layer: formed by interdigitating podocytes
These create a sieve that allows small, charged ions through
Pathophysiology of glomerulonephritis
Antibody / T cell mediated immunological attack upon an antigen in the glomerulus which may be primary (always there) or secondary (acquired)
Examinations / investigations in AKI
Obs : hypotension = pre renal / hypertension = CKD
OE: palpable bladder = bladder outlet obstruction
Urine dip and MCS
Bloods
VBG /ABG: to assess acid / base status
ECG: hyperkalaemia
Renal USS: to look for post renal causes
Management of AKI
- Halt any damaging drugs eg ACEi / NSAIDs
- Treat pre renal causes with iv fluids
- Refer to urology to relieve obstruction
- Assess fluid status with volume replacement
Indications for acute dialysis
Refractory hyperkalaemia
Refractory acidosis
Pulmonary oedema
Uraemic pericarditis / encephalopathy
Causes of hyperkalaemia
AKI / CKD
Drugs: supplements, K sparing diuretics, ACEis, NSAIDs
Acidosis
Others: addisons / tumour lysis syndrome / burns
How does hyperkalaemia present on ECG
Tall, peaked T waves
Widened QRS complex
Flattened P waves / prolonged PR interval
What to do if there is >6.5mmol/L potassium or there are ECG changes
- Start continuous ECG monitoring
- 10ml of 10% calcium gluconate IV to stabilise myocardium (repeat at 5min intervals until a max of 3 doses)
- 50ml of 50% glucose with 10U ACTRAPID insulin into a large vein over 30mins to decrease K+ conc
- Consider 10mg salbutamol neb
- If pH <7.2 consider sodium bicarbonate IV if advised by renal reg
- Recheck K+ after 2 hours
- Calcium resonium can then be given orally / rectally - long term option
- Ensure underlying cause is being treated
What is benign prostatic hyperplasia
Benign nodular / diffuse proliferation of glandular layers of the prostate, leading to enlargement of the inner transitional zone
Affects 70% of those >70
BPH symptoms
Filling: urinary freq (nocturia), urinary urgency
Voiding: hesitancy, poor stream, post void dribbling, strangury, retention with overflow incontinence
Complications: haematuria, UTI, post renal aki
BPB investigations
PR: enlarged prostate, typically the sulcus is still palpable
Bloods: FBC, U&E, PSA
Urinalysis
Bladder USS
Transrectal USS
BPH complications
UTI
Overflow incontinence
Bladder calculi
Bladder diverticulae
Bilateral hydronephrosis and renal failure
Management of BPH
Acute:
- catheter to relieve obstruction (urethral or suprapubic)
Chronic:
- lifestyle: avoid alcohol + caffeine, relax when voiding, void twice in a row to help emptying, bladder retraining therapy
Alpha blockers: reduce SM tone
5a-reductase inhibitors: stop conversion of testosterone to dihydrotestosterone thus decreasing enlargement
Surgical management of BPH
Transurethral resection of the prostate
- 10% risk of impotence and 20% need repeat in 10years
- retrograde ejaculation almost universal
- bleeding
- hyponatraemia
Holmium laser prostatectomy
- endoscopic procedure used for very large prostates
- urinary incontinence may occur if too much gland is removed
Epidemiology of PCa
2nd most common malignancy in males
Present in 80% of males >80 but only 4% die from it
Slowly progressive malignancy
Mainly adenocarcinomas arising in peripheral prostate
PCa risk factors
Age
FH
Black ethnicity
Raised testosterone levels
PCa presentation
- often asymptomatic (found on PR)
- may present with filling, voiding or complication symptoms
- weight loss / bone pain suggest advanced metastatic disease
PR findings in prostate examinations
Hard ‘craggy’ prostate
PSA levels in PCa
> 10mg/ml highly suggestive of tumour
Not a reliable screening method as can be affected by many factors such as cycling, UTI, recent intercourse and catheterisation
Gleason scoring for PCa
2 areas of biopsied tissue are graded out of 5 in terms of histological features of aggression to give a combined score out of 10
Gleason grade is vital for prognosis with scores of <6 being low risk and >8 being high risk
What is the D’amico risk stratification
Combines gleason score with clinical stage and PSA to give a more accurate prognostic score than gleason score
Management of T1/T2 prostate cancer
Patient choice between:
- active surveillance - regular PSA / DRE / biopsy
- curative surgery : radical prostatectomy
- curative radiotherapy / brachytherapy
Management of T3/T4 prostate cancer
Choice between radiotherapy or surgery
Management of metastatic prostate cancer
Hormonal therapy is first line aiming to decrease the stimulatory effect of testosterone on PCa cell division
- androgen deprivation / blockade
Chemotherapy - used if relapsed on hormonal therapy
Prognosis of PCa
Has a 5 year survival rate of over 95% when diagnosed at stage 1-3
This falls to 49% of those with stage 4
Most common malignancy affecting the urinary system
Bladder cancer
What type of cell is mainly affected in bladder cancer
Transitional cell
Clinical features of bladder cancer
Painless frank haematuria
Lower urinary tract symptoms (frequency, urgency, dysuria)
Symptoms of bladder outlet obstruction (urinary retention / post renal AKI)
Fever
Weight loss
Malaise
Risk factors for bladder cancer
Smoking
Aromatic amines: rubber, plastic, dye
Chronic cystitis
Pelvic irradiation
Bladder cancer investigations
Urinalysis
Any painless haematuria should be assumed malignant (2WW referral for cystoscopy)
Any suspicious lesion will be biopsied or resected via a transurethral resection of bladder tumour
CT abdo
Treatment for bladder cancer T1 bladder carcinomas
Transurethral resection of bladder tumour performed at cystoscopy with intravesical chemotherapy
5 year survival 95%
Treatment of T2-T3 bladder carcinomas
Radical cystectomy is gold standard with pre-operative chemo
An ileal conduit is used to leave an urostomy
Treatment of T4 bladder carcinomas (invasion beyond bladder)
Palliative care
Risk factors of SCC of the bladder
Schistosomiasis
Bladder calculi
Chronic UTI
2 types of renal tumours
Vascular tumours that arise from the proximal tubular epithelium (90%)
TCC’s of the renal pelvis
Risk factors for renal cancer
Male
Smoking
HTN
Polycystic kidney disease
Chronic haemodialysis
Presentation of renal cancer
50% incidental findings
10% present with classic triad: haematuria, loin pain, abdo mass
- constitutional symptoms
- varicocele due to invasion of left renal vein
- polycythaemia
Renal cancer investigations
Urine cytology
USS to differentiate between solid and cystic mass
CT / MRI for tumour staging
Cannon ball lung metastases on CXR
Brain metastases also common
Treatment of renal cell carcinomas
Radical nephrectomy
Partial nephrectomy (if smaller than 5cm)
Post op immunotherapy
65% 5 year survival for renal disease treated surgically
What is a wilm’s tumour
Comprise 20% of childhood malignancies
Undifferentiated mesodermal tumour
Present generally at 3.5yrs with flank pain and abdo mass
Should not be biopsied
Tx:
- nephrectomy and pre-operative chemo
Aetiology of urinary tract calculi
Renal calculi form in the collecting ducts of the kidney and may then be deposited anywhere from the renal pelvis to the urethra
Commonly composed of calcium oxalate
15% lifetime risk
Peak age 20-40
M:F 3:1
Presentation of urinary tract calculi
Renal colic: excruciating loin to groin spasms with N&V, patient cannot lie still
Occurs if stone is impacted in the ureter
Dull loin pain - if the stone is in a major / minor calyx
UTI - secondary to the partial / complete obstruction
Risk factors for urinary tract calculi
Obesity
Dehydration / low fluid intake
FH / personal history of stone disease
Anatomical abnormalities
Investigations for suspected urinary tract calculi
Bloods
Urine dip
Urine MCS
Imaging : non contrast CT KUB
Acute management of urinary tract calculi
A-E assessment
75mg Diclofenac IM unless contraindicated
Avoid NSAID in the presence of AKI
IM metoclopramide if N&V
IV abx if signs of infection - infected obstructed kidney is surgical emergency
When should admission be indicated in urinary tract calculi
If there is still severe pain at 1hr
Risk of AKI
Signs of shock / infection
Uncertainty over diagnosis
Indications for active treatment in urinary tract calculi
Low chance of spontaneous passage
Persistent pain
Ongoing obstruction
Signs of infection
Renal insufficiency
What is extracorporeal shockwave lithotripsy (for urinary tract calculi)
Outpatient procedure that focuses shockwaves on the stone to break it up and it can then be passed spontaneously
What is uretoscopy
Various energy sources eg laser can be used to break up the stone